{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:02:52Z","timestamp":1769302972551,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,16]]},"DOI":"10.7759\/cureus.69514","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:27:47Z","timestamp":1726486067000},"source":"Crossref","is-referenced-by-count":3,"title":["Optimizing Desolvation Conditions for Glutathione-Cross-Linked Bovine Serum Albumin Nanoparticles: Implication for Intravenous Drug Delivery"],"prefix":"10.7759","author":[{"given":"Hamid J","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mowafaq M","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5455\/jcmr.2023.14.03.02","article-title":"Principles and advantages of new drug delivery technologies","volume":"14","author":"Alkufi HK","year":"2023","unstructured":"Alkufi HK, Salman AH, Taher SS. Principles and advantages of new drug delivery technologies. J Complement Med Res. 2023, 14:6-9. 10.5455\/jcmr.2023.14.03.02","journal-title":"J Complement Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-019-05211-0","article-title":"Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery","volume":"27","author":"Zahin N","year":"2020","unstructured":"Zahin N, Anwar R, Tewari D, et al.. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery. Environ Sci Pollut Res Int. 2020, 27:19151-68. 10.1007\/s11356-019-05211-0","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.31351\/vol29iss2pp70-79","article-title":"Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery","volume":"29","author":"Noor AH","year":"2020","unstructured":"Noor AH, Ghareeb MM. Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery. Iraqi J Pharm Sci. 2020, 29:70-9. 10.31351\/vol29iss2pp70-79","journal-title":"Iraqi J Pharm Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10853-019-03486-9","article-title":"Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel","volume":"54","author":"Wang D","year":"2019","unstructured":"Wang D, Liang N, Kawashima Y, Cui F, Yan P, Sun S. Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel. J Mater Sci. 2019, 54:8613-26. 10.1007\/s10853-019-03486-9","journal-title":"J Mater Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.33640\/2405-609X.3359","article-title":"Designing of human serum albumin nanoparticles for drug delivery: a potential use of anticancer treatment","volume":"10","author":"Al-Ani A","year":"2024","unstructured":"Al-Ani A, Alsahlanee R. Designing of human serum albumin nanoparticles for drug delivery: a potential use of anticancer treatment. Karbala Int J Mod Sci. 2024, 10:306-17. 10.33640\/2405-609X.3359","journal-title":"Karbala Int J Mod Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.05.032","article-title":"A simple improved desolvation method for the rapid preparation of albumin nanoparticles","volume":"91","author":"Jahanban-Esfahlan A","year":"2016","unstructured":"Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016, 91:703-9. 10.1016\/j.ijbiomac.2016.05.032","journal-title":"Int J Biol Macromol"},{"key":"ref7","article-title":"Formulation and evaluation of nimodipine nanoparticles incorporated within orodispersible tablets","volume":"10","author":"Alhagiesa AW","year":"2020","unstructured":"Alhagiesa AW, Ghareeb MM. Formulation and evaluation of nimodipine nanoparticles incorporated within orodispersible tablets. Int J Drug Deliv Technol. 2020, 10:547-52.","journal-title":"Int J Drug Deliv Technol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03832-3","article-title":"Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique","volume":"83","author":"Kimura K","year":"2019","unstructured":"Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M. Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol. 2019, 83:1113-20. 10.1007\/s00280-019-03832-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123011","article-title":"Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer","volume":"13","author":"Prajapati R","year":"2021","unstructured":"Prajapati R, Garcia-Garrido E, Somoza \u00c1. Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer. Cancers (Basel). 2021, 13:3011. 10.3390\/cancers13123011","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.71.e116917","article-title":"Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes","volume":"71","author":"Naji GH","year":"2024","unstructured":"Naji GH, Al Gawhari FJ. Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes. Pharmacia. 2024, 71:1-7. 10.3897\/pharmacia.71.e116917","journal-title":"Pharmacia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.31351\/vol32iss3pp71-84","article-title":"Preparation, in-vitro, and ex-vivo evaluation of ondansetron loaded Invasomes for transdermal delivery","volume":"32","author":"Salih OS","year":"2023","unstructured":"Salih OS, Al-Akkam EJ. Preparation, in-vitro, and ex-vivo evaluation of ondansetron loaded Invasomes for transdermal delivery. Iraqi J Pharm Sci. 2023, 32:71-84. 10.31351\/vol32iss3pp71-84","journal-title":"Iraqi J Pharm Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15171\/ijb.1168","article-title":"The effects of organic solvents on the physicochemical properties of human serum albumin nanoparticles","volume":"14","author":"Mohammad-Beigi H","year":"2016","unstructured":"Mohammad-Beigi H, Shojaosadati SA, Morshedi D, Mirzazadeh N, Arpanaei A. The effects of organic solvents on the physicochemical properties of human serum albumin nanoparticles. Iran J Biotechnol. 2016, 14:45-50. 10.15171\/ijb.1168","journal-title":"Iran J Biotechnol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2014.04.011","article-title":"Theory and practice of size exclusion chromatography for the analysis of protein aggregates","volume":"101","author":"Fekete S","year":"2014","unstructured":"Fekete S, Beck A, Veuthey JL, Guillarme D. Theory and practice of size exclusion chromatography for the analysis of protein aggregates. J Pharm Biomed Anal. 2014, 101:161-73. 10.1016\/j.jpba.2014.04.011","journal-title":"J Pharm Biomed Anal"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.08.003","article-title":"Albumin-encapsulated liposomes: a novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core","volume":"107","author":"Okamoto Y","year":"2018","unstructured":"Okamoto Y, Taguchi K, Yamasaki K, Sakuragi M, Kuroda S, Otagiri M. Albumin-encapsulated liposomes: a novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core. J Pharm Sci. 2018, 107:436-45. 10.1016\/j.xphs.2017.08.003","journal-title":"J Pharm Sci"},{"key":"ref15","article-title":"Innovative analytical methodologies for the development of new antitubercular agents","author":"Rinaldi F","year":"2018","unstructured":"Rinaldi F. Innovative analytical methodologies for the development of new antitubercular agents. Universit\u00e0 Degli Studi Di Pavia. 2018, 1-154.","journal-title":"Universit\u00e0 Degli Studi Di Pavia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.09.046","article-title":"Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems","volume":"173","author":"Ferrado JB","year":"2019","unstructured":"Ferrado JB, Perez AA, Visentini FF, Islan GA, Castro GR, Santiago LG. Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems. Colloids Surf B Biointerfaces. 2019, 173:43-51. 10.1016\/j.colsurfb.2018.09.046","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57787-4","article-title":"Bio synthesis, comprehensive characterization, and multifaceted therapeutic applications of BSA-resveratrol coated platinum nanoparticles","volume":"14","author":"Faisal S","year":"2024","unstructured":"Faisal S, Tariq MH, Abdullah, et al.. Bio synthesis, comprehensive characterization, and multifaceted therapeutic applications of BSA-resveratrol coated platinum nanoparticles. Sci Rep. 2024, 14:7875. 10.1038\/s41598-024-57787-4","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejbas.2017.11.002","article-title":"Synthesis, characterization and anticancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line","volume":"5","author":"Kumar N","year":"2018","unstructured":"Kumar N, Salar RK, Prasad M, Ranjan K. Synthesis, characterization and anticancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line. Egypt J Basic Appl Sci. 2018, 5:87-99. 10.1016\/j.ejbas.2017.11.002","journal-title":"Egypt J Basic Appl Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.31351\/vol28iss2pp17-23","article-title":"Synthesis, characterization and preliminary cytotoxic activity study of new 5-fluorouracil conjugate with pyrrolidine dithiocarbamate as a mutual anticancer prodrug","volume":"28","author":"Shihab IK","year":"2019","unstructured":"Shihab IK, Mohammed MH. Synthesis, characterization and preliminary cytotoxic activity study of new 5-fluorouracil conjugate with pyrrolidine dithiocarbamate as a mutual anticancer prodrug. Iraqi J Pharm Sci. 2019, 28:17-23. 10.31351\/vol28iss2pp17-23","journal-title":"Iraqi J Pharm Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.54133\/ajms.v7i1.1137","article-title":"Cytotoxicity of sericin nanoparticles loaded with paclitaxel as a pulmonary drug delivery system: in vitro and in vivo studies","volume":"7","author":"Kadhim ME","year":"2024","unstructured":"Kadhim ME, Rajab NA. Cytotoxicity of sericin nanoparticles loaded with paclitaxel as a pulmonary drug delivery system: in vitro and in vivo studies. Al-Rafidain J Med Sci. 2024, 7:144-52. 10.54133\/ajms.v7i1.1137","journal-title":"Al-Rafidain J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c20-00222","article-title":"Characterization of bovine lactoferrin nanoparticle prepared by desolvation technique","volume":"68","author":"Taguchi K","year":"2020","unstructured":"Taguchi K, Chuang V, Hashimoto M, et al.. Characterization of bovine lactoferrin nanoparticle prepared by desolvation technique. Chem Pharm Bull. 2020, 68:766-72. 10.1248\/cpb.c20-00222","journal-title":"Chem Pharm Bull"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2015.08.070","article-title":"Impact of extraction and elution media on non-size effects in size exclusion chromatography of proteins","volume":"1415","author":"Lambrecht MA","year":"2015","unstructured":"Lambrecht MA, Rombouts I, Van Kelst L, Delcour JA. Impact of extraction and elution media on non-size effects in size exclusion chromatography of proteins. J Chromatogr A. 2015, 1415:100-7. 10.1016\/j.chroma.2015.08.070","journal-title":"J Chromatogr A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fsens.2022.1087115","article-title":"Quality control and purification of ready-to-use conjugated gold nanoparticles to ensure effectiveness in biosensing","volume":"3","author":"Wang J","year":"2022","unstructured":"Wang J, Giordani S, Marassi V, Roda B, Reschiglian P, Zattoni A. Quality control and purification of ready-to-use conjugated gold nanoparticles to ensure effectiveness in biosensing. Front Sens. 2022, 3:1-13. 10.3389\/fsens.2022.1087115","journal-title":"Front Sens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1039\/C5RA13838H","article-title":"Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment","volume":"5","author":"Akrami M","year":"2015","unstructured":"Akrami M, Khoobi M, Khalilvand-Sedagheh M, et al.. Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment. RSC Adv. 2015, 5:88096-107. 10.1039\/C5RA13838H","journal-title":"RSC Adv"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionut.2012.10.009","article-title":"Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells","volume":"3","author":"Karthikeyan","year":"2013","unstructured":"Karthikeyan, S, Prasad NR, Ganamani A, Balamurugan E. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomedicine & Preventive Nutrition. 2013, 3:64-73. 10.1016\/j.bionut.2012.10.009","journal-title":"Biomedicine & Preventive Nutrition"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/02652048.2011.635218","article-title":"Albumin nanoparticles with predictable size by desolvation procedure","volume":"29","author":"von Storp B","year":"2012","unstructured":"von Storp B, Engel A, Boeker A, Ploeger M, Langer K. Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul. 2012, 29:138-46. 10.3109\/02652048.2011.635218","journal-title":"J Microencapsul"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7939\/R3J96097M","article-title":"Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells","volume":"9","author":"Abrams D","year":"2006","unstructured":"Abrams D, Huang Y, McQuarrie S, et al.. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. J Pharm Pharm Sci. 2006, 9:124-32. 10.7939\/R3J96097M","journal-title":"J Pharm Pharm Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4838(98)00121-6","article-title":"Acetonitrile-protein interactions: amino acid solubility and preferential solvation","volume":"1387","author":"Gekko K","year":"1998","unstructured":"Gekko K, Ohmae E, Kameyama K, Takagi T. Acetonitrile-protein interactions: amino acid solubility and preferential solvation. Biochim Biophys Acta. 1998, 1387:195-205. 10.1016\/S0167-4838(98)00121-6","journal-title":"Biochim Biophys Acta"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms12095797","article-title":"Role of \u03b1-helical structure in organic solvent-activated homodimer of elastase strain K","volume":"12","author":"Rahman RN","year":"2011","unstructured":"Rahman RN, Salleh AB, Basri M, Wong CF. Role of \u03b1-helical structure in organic solvent-activated homodimer of elastase strain K. Int J Mol Sci. 2011, 12:5797-814. 10.3390\/ijms12095797","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/1087057105284218","article-title":"DMSO-related effects in protein characterization","volume":"11","author":"Tjernberg A","year":"2006","unstructured":"Tjernberg A, Markova N, Griffiths WJ, Hall\u00e9n D. DMSO-related effects in protein characterization. J Biomol Screen. 2006, 11:131-7. 10.1177\/1087057105284218","journal-title":"J Biomol Screen"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji KD","year":"2014","unstructured":"Ratanji KD, Derrick JP, Dearman RJ, Kimber I. Immunogenicity of therapeutic proteins: influence of aggregation. J Immunotoxicol. 2014, 11:99-109. 10.3109\/1547691X.2013.821564","journal-title":"J Immunotoxicol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2010.07.016","article-title":"Thermal aggregation of bovine serum albumin studied by asymmetrical flow field-flow fractionation","volume":"675","author":"Yohannes G","year":"2010","unstructured":"Yohannes G, Wiedmer SK, Elomaa M, Jussila M, Aseyev V, Riekkola ML. Thermal aggregation of bovine serum albumin studied by asymmetrical flow field-flow fractionation. Anal Chim Acta. 2010, 675:191-8. 10.1016\/j.aca.2010.07.016","journal-title":"Anal Chim Acta"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464870","article-title":"Optimization and uncertainty assessment of a gas chromatography coupled to Orbitrap mass spectrometry method to determine organic contaminants in blood: a case study of an endangered seabird","volume":"1722","author":"Or\u00f3-Nolla B","year":"2024","unstructured":"Or\u00f3-Nolla B, Campioni L, Lacorte S. Optimization and uncertainty assessment of a gas chromatography coupled to Orbitrap mass spectrometry method to determine organic contaminants in blood: a case study of an endangered seabird. J Chromatogr A. 2024, 1722:464870. 10.1016\/j.chroma.2024.464870","journal-title":"J Chromatogr A"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21974","article-title":"The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals","volume":"99","author":"Arakawa T","year":"2010","unstructured":"Arakawa T, Ejima D, Li T, Philo JS. The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals. J Pharm Sci. 2010, 99:1674-92. 10.1002\/jps.21974","journal-title":"J Pharm Sci"},{"key":"ref35","article-title":"Organic volatile impurities: a regulatory overview","volume":"44","author":"Kushwaha P","year":"2012","unstructured":"Kushwaha P. Organic volatile impurities: a regulatory overview. Pharma Times. 2012, 44:25-30.","journal-title":"Pharma Times"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294898-optimizing-desolvation-conditions-for-glutathione-cross-linked-bovine-serum-albumin-nanoparticles-implication-for-intravenous-drug-delivery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:27:53Z","timestamp":1726486073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294898-optimizing-desolvation-conditions-for-glutathione-cross-linked-bovine-serum-albumin-nanoparticles-implication-for-intravenous-drug-delivery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.69514","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}